Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Coherus Biosciences ( (CHRS) ) has shared an update.
Kimberly J. Tzoumakas has announced her resignation from the Board of Directors of Coherus BioSciences, Inc., effective December 31, 2024. Her departure is amicable, with no disagreements over company operations or policies, reflecting a positive relationship and her valued contributions during her time with the board.
See more data about CHRS stock on TipRanks’ Stock Analysis page.
